IA
AGL icon

IFP Advisors’s Agilon Health AGL Stock Holding History

IFP Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3K Sell
227
-6,160
-96% -$403K ﹤0.01% 2852
2026
Q1 		$3.78K Buy
6,387
+6,077
+1,960% +$98.3K ﹤0.01% 3688
2025
Q4 		$5.34K Buy
310
+307
+10,233% +$5.95K ﹤0.01% 3376
2025
Q3 		$66 Sell
3
-19
-86% -$718 ﹤0.01% 4611
2025
Q2 		$1.28K Buy
22
+20
+1,000% +$1.6K ﹤0.01% 4114
2025
Q1 		$229 Sell
2
-5
-71% -$435 ﹤0.01% 3628
2024
Q4 		$363 Sell
7
-82
-92% -$4.96K ﹤0.01% 3503
2024
Q3 		$8.77K Sell
89
-5
-5% -$646 ﹤0.01% 2476
2024
Q2 		$15.3K Buy
+94
New +$13.4K ﹤0.01% 2183
2024
Q1 		– Hold
0
– – – 3089
2023
Q4 		– Hold
0
– – – 2989
2023
Q3 		– Sell
-2
Closed -$815 – 3296
2023
Q2 		$815 Hold
2
– – ﹤0.01% 3123
2023
Q1 		$1.46K Sell
2
-32
-94% -$17.9K ﹤0.01% 2989
2022
Q4 		$26K Sell
34
-15
-31% -$7.04K ﹤0.01% 2683
2022
Q3 		$38K Buy
49
+34
+227% +$20.4K ﹤0.01% 2572
2022
Q2 		$12K Hold
15
– – ﹤0.01% 3238
2022
Q1 		$12K Buy
+15
New +$7.73K ﹤0.01% 3238

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

IFP Advisors's AGL Position: Q2 2026 in Review

IFP Advisors reduced its Agilon Health (AGL) stake by 96% in Q2 2026, selling an estimated $403K and leaving 227 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2852.

IFP Advisors first reported a position in AGL in Q1 2022 and has held it in 15 quarters since. The position peaked at $38K in Q3 2022. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • IFP Advisors held 227 shares of Agilon Health worth $24.3K as of Q2 2026.
  • IFP Advisors sold 6,160 Agilon Health shares in Q2 2026, an estimated $403K.
  • Agilon Health made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2852 holding.
  • IFP Advisors first reported a position in Agilon Health in Q1 2022 and has held it in 15 quarters since.
  • IFP Advisors's Agilon Health position peaked at $38K in Q3 2022.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.